Your Article Summary
See Latest ArticlesLess radiographic progression with adalimumab plus methotrexate versus methotrexate monotherapy across the spectrum of clinical response in early rheumatoid arthritis
Journal of Rheumatology, 07/02/09
Emery P et al. – Study demonstrates that adalimumab plus methotrexate (MTX) therapy resulted in less radiographic progression than MTX monotherapy across the spectrum of clinical response in pts with early rheumatoid arthritis (RA).
Methods- Aim was to determine the relationship between radiographic progression and clinical response for adalimumab plus MTX vs either monotherapy in RA pts
- Pts with early RA who received adalimumab plus MTX (n=240), adalimumab (n=222), or MTX (n=216) were grouped by:
- American College of Rheumatology (ACR) response
- 28-joint Disease Activity Score (DAS28), or
- Remission-like state
- at 26 and 104 wks
- Radiographic progression was assessed by cumulative probability plots, mean changes in total Sharp score (ΔTSS), and percentages of progressors (ΔTSS >0.5)
- Therapy with adalimumab plus MTX permitted less radiographic progression at wks 26 and 104 than MTX monotherapy
- Adalimumab monotherapy was generally intermediate
- A strong, proportional relationship was observed between clinical response and radiographic efficacy only for MTX monotherapy
- Monotherapies approximated the radiographic efficacy of adalimumab plus MTX only among remission-like responders
- Although progression was greater with MTX monotherapy vs adalimumab plus MTX for pts with TJC=0
- Concurrent clinical and radiographic remission was more frequent at wk 104 with adalimumab plus MTX vs adalimumab or MTX monotherapy
Related Articles
Treatment of early RA with infliximab is beneficial
American Pharmacists Association, 11/06/09
Relevance Score: 82%
Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
Arthritis Research & Therapy, 10/02/09
Relevance Score: 82%
Pain in arthritis
European Journal of Pain, 11/17/09
Relevance Score: 81%
Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents. A Cost-Effectiveness Analysis
Annals of Internal Medicine, 11/05/09
Relevance Score: 81%
Articular ultrasonography in rheumatoid arthritis
International Journal of Clinical Rheumatology, 10/16/09
Relevance Score: 81%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/07/09
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Bone marrow edema is the most specific finding for rheumatoid arthritis (RA) on noncontrast magnetic resonance imaging of the hands and wrists: A comparison of patients with RA and healthy controls
Journal of Rheumatology, 12/07/09
Is there any relationship between serum and urine neopterin and serum interferon-gamma levels in the activity of Behcet's disease?
Journal of the European Academy of Dermatology and Venereology, 12/04/09
Role of Imaging in Spine, Hand, and Wrist Osteoarthritis
Rheumatic Disease Clinics of North America, 12/01/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
TNF{alpha} blockade therapy reduces circulating NT-proBNP levels in RA patients with active disease: Results from prospective cohort study
Annals of Rheumatic Diseases, 12/07/09
Silica exposure among male current smokers is associated with a high risk of developing ACPA positive rheumatoid arthritis
Annals of Rheumatic Diseases, 12/07/09